The DOI matches its Crossref record; 74 of the 74 references it cites were found in a registry or an index.
A Next Generation Connectivity Map: L1000 Platform and the First 1,000,000 Profiles
Open accessPublished version of a preprint
Abstract
We previously piloted the concept of a Connectivity Map (CMap), whereby genes, drugs, and disease states are connected by virtue of common gene-expression signatures. Here, we report more than a 1,000-fold scale-up of the CMap as part of the NIH LINCS Consortium, made possible by a new, low-cost, high-throughput reduced representation expression profiling method that we term L1000. We show that L1000 is highly reproducible, comparable to RNA sequencing, and suitable for computational inference of the expression levels of 81% of non-measured transcripts. We further show that the expanded CMap can be used to discover mechanism of action of small molecules, functionally annotate genetic variants of disease genes, and inform clinical trials. The 1.3 million L1000 profiles described here, as well as tools for their analysis, are available at https://clue.io.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“The magnitude of gene expression changes has been reported to correlate with functional impact (Wawer et al. 2014; Subramanian et al. 2017)”
From Murine single-cell RNA-seq reveals cell-identity- and tissue-specific trajectories of aging (2019) · cites this paper as Subramanian et al. 2017
Experimental — accuracy not yet measuredIn the citing paper
“many transcriptional states could be faithfully inferred from a subset of gene expression measurements32,33”
From Combinatorial single-cell CRISPR screens by direct guide RNA capture and targeted sequencing (2020) · cites this paper as [33]
In the citing paper
“Alternatively, gene panels such as the L1000 panel34 could be used (Extended Data Figure 3), which has been shown to capture the majority of information contained in the full transcriptome across a wide range of perturbations34.”
From Targeted Perturb-seq enables genome-scale genetic screens in single cells (2020) · cites this paper as [34]
In the citing paper
“Perturbation modelling is underpinned by systematic databases of biological response to treatment (e.g. Connectivity Map [2], L1000, DRUG-seq [3]) and leverages the significant potential of machine learning (ML) to make predictive models, e.g., molecular targets or IC50 values.”
From A mini-review on perturbation modelling across single-cell omic modalities (2024) · cites this paper as [2]
In the citing paper
“Of note, the LINCS consortium, and in particular the L1000 Connectivity Map resource, provides a catalog of postperturbation transcriptomics profiles for thousands of compounds, offering a global map of the phenotypic response landscape of the medicinal chemistry space.205”
From Advancing Targeted Protein Degradation via Multiomics Profiling and Artificial Intelligence (2023) · cites this paper as [205]
In the citing paper
“Another caveat of our approach is the likely existence of null signatures corresponding to innocuous molecules with no actual bioactivity in a given CC data type38.”
From Bioactivity descriptors for uncharacterized chemical compounds (2021) · cites this paper as [38]
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Subramanian, A., Tamayo, P., Mootha, V. K., Mukherjee, S., Ebert, B. L., Gillette, M. A., Paulovich, A., Pomeroy, S. L., Golub, T. R., Lander, E. S., et al. (2005) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0506580102 · Cited by 53,625
Self-citation(2008) · Journal of Machine Learning Research · Cited by 33,051
Cluster analysis and display of genome-wide expression patterns
Eisen, M. B., Spellman, P. T., Brown, P. O., & Botstein, D. (1998) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.95.25.14863 · Cited by 16,184
Gene Expression Omnibus: NCBI gene expression and hybridization array data repository
Edgar, R. (2002) · Nucleic Acids Research · doi:10.1093/nar/30.1.207 · Cited by 13,288
Open Babel: An open chemical toolbox
O'Boyle, N. M., Banck, M. S., James, C. A. J., Morley, C., Vandermeersch, T., & Hutchison, G. R. (2011) · Journal of Cheminformatics · doi:10.1186/1758-2946-3-33 · Cited by 10,745
Adjusting batch effects in microarray expression data using empirical Bayes methods
Johnson, W. E., Li, C., & Rabinovic, A. (2007) · Biostatistics · doi:10.1093/biostatistics/kxj037 · Cited by 8,658
<tt>BLAT</tt> —The <tt>BLAST</tt> -Like Alignment Tool
Kent, W. J. (2002) · Genome Research · doi:10.1101/gr.229202 · Cited by 8,480
Lamb, J., Crawford, E. D., Peck, D., Modell, J. W., Blat, I. C., Wrobel, M. J., Lerner, J., Brunet, J.-P., Subramanian, A., Ross, K. N., et al. (2006) · Science · doi:10.1126/science.1132939 · Cited by 5,257
Self-citationThe Genotype-Tissue Expression (GTEx) pilot analysis: Multitissue gene regulation in humans
The GTEx Consortium, Ardlie, K. G., Deluca, D. S., Segrè, A. V., Sullivan, T. J., Young, T. R., Gelfand, E. T., Trowbridge, C. A., Maller, J. B., Tukiainen, T., et al. (2015) · Science · doi:10.1126/science.1262110 · Cited by 5,062
Self-citationDefining a Cancer Dependency Map
Tsherniak, A., Vazquez, F., Montgomery, P. G., Weir, B. A., Kryukov, G., Cowley, G. S., Gill, S., Harrington, W. F., Pantel, S., Krill-Burger, J. M., et al. (2017) · Cell · doi:10.1016/j.cell.2017.06.010 · Cited by 3,276
Self-citation
Research works printed but not linked: 1
- Illumina Inc. (2007). BeadStudio Normalization Algorithms for Gene Expression Data (Illumina Technical Bulletin Pub. No.470-2007-005).
Cited by
Sorted by citations
Items 101–200 of 1,010
Changing Trends in Computational Drug Repositioning
Yella, J., Yaddanapudi, S., Wang, Y., & Jegga, A. G. (2018) · Pharmaceuticals · doi:10.3390/ph11020057 · Cited by 171
Liu, W., Xie, L., He, Y.-H., Wu, Z.-Y., Liu, L.-X., Bai, X., Deng, D.-X., Xu, X., Liao, L.-D., Lin, W., et al. (2021) · Nature Communications · doi:10.1038/s41467-021-25202-5 · Cited by 178
An update on Drug Repurposing: Re-written saga of the drug’s fate
S, H. S. G. N., Saraswathy, G. R., Murahari, M., & Krishnamurthy, M. (2018) · Biomedicine & Pharmacotherapy · doi:10.1016/j.biopha.2018.11.127 · Cited by 164
Yang, C. G., Zhang, H., Chen, M., Wang, S., Qian, R., Zhang, L., Huang, X., Wang, J., Liu, Z., Qin, W., et al. (2022) · eLife · doi:10.7554/elife.71880 · Cited by 161
Self-citationChen, D., Liu, J., Zang, L., Xiao, T., Zhang, X., Li, Z., Zhu, H., Gao, W., & Yu, X. (2021) · International Journal of Biological Sciences · doi:10.7150/ijbs.66913 · Cited by 162
Causal integration of multi‐omics data with prior knowledge to generate mechanistic hypotheses
Dugourd, A., Kuppe, C., Sciacovelli, M., Gjerga, E., Gabor, A., Emdal, K. B., Vieira, V., Bekker‐Jensen, D. B., Kranz, J., Bindels, E. M. J., et al. (2021) · Molecular Systems Biology · doi:10.15252/msb.20209730 · Cited by 149
Connecting omics signatures and revealing biological mechanisms with iLINCS
Pilarczyk, M., Fazel‐Najafabadi, M., Kouril, M., Shamsaei, B., Vasiliauskas, J., Niu, W., Mahi, N. A., Zhang, L., Clark, N. A., Ren, Y., et al. (2022) · Nature Communications · doi:10.1038/s41467-022-32205-3 · Cited by 154
Ortmayr, K., Dubuis, S., & Zampieri, M. (2019) · Nature Communications · doi:10.1038/s41467-019-09695-9 · Cited by 142
Molecular cascades and cell type–specific signatures in ASD revealed by single-cell genomics
Wamsley, B., Bicks, L. K., Cheng, Y., Kawaguchi, R., Quintero, D., Grundman, J., Liu, J., Xiao, S., Hawken, N., Margolis, M., et al. (2024) · Science · doi:10.1126/science.adh2602 · Cited by 155
Yang, X., Liu, G., Feng, G., Bu, D., Wang, P., Jiang, J., Chen, S., Yang, Q., Zhang, Y., Man, Z., et al. (2023) · doi:10.1101/2023.09.26.559542 · Cited by 148
Drug repurposing screening and mechanism analysis based on human colorectal cancer organoids
Mao, Y., Wang, W., Yang, J., Zhou, X., Lu, Y., Gao, J., Wang, X., Wen, L., Fu, W., & Tang, F. (2023) · Protein & Cell · doi:10.1093/procel/pwad038 · Cited by 155
Yang, X., Liu, G., Feng, G., Bu, D., Wang, P., Jiang, J., Chen, S., Yang, Q., Miao, H., Zhang, Y., et al. (2024) · Cell Research · doi:10.1038/s41422-024-01034-y · Cited by 148
Responsible, practical genomic data sharing that accelerates research
Byrd, J. B., Greene, A. C., Prasad, D. V., Jiang, X., & Greene, C. S. (2020) · Nature Reviews Genetics · doi:10.1038/s41576-020-0257-5 · Cited by 163
A compendium of kinetic modulatory profiles identifies ferroptosis regulators
Conlon, M., Poltorack, C. D., Forcina, G. C., Armenta, D. A., Mallais, M., Perez, M. A., Wells, A. C., Kahanu, A., Magtanong, L., Watts, J. L., et al. (2021) · Nature Chemical Biology · doi:10.1038/s41589-021-00751-4 · Cited by 152
Bioinformatics Approaches for Anti-cancer Drug Discovery
Li, K., Du, Y., Li, L., & Wei, D. (2019) · Current Drug Targets · doi:10.2174/1389450120666190923162203 · Cited by 145
Ursu, O., Holmes, J., Bologa, C., Yang, J. J., Mathias, S. L., Stathias, V., Nguyễn, Ð.-T., Schürer, S. C., & Oprea, T. I. (2018) · Nucleic Acids Research · doi:10.1093/nar/gky963 · Cited by 145
Predicting cell health phenotypes using image-based morphology profiling
Way, G. P., Kost‐Alimova, M., Shibue, T., Harrington, W. F., Gill, S., Piccioni, F., Becker, T., Shafqat-Abbasi, H., Hahn, W. C., Carpenter, A. E., et al. (2021) · Molecular Biology of the Cell · doi:10.1091/mbc.e20-12-0784 · Cited by 145
Self-citationWang, Z., Wang, Y., Yang, T., Xing, H., Wang, Y., Gao, L., Guo, X., Xing, B., Wang, Y., & Ma, W. (2021) · Briefings in Bioinformatics · doi:10.1093/bib/bbab032 · Cited by 144
Comprehensive Survey of Recent Drug Discovery Using Deep Learning
Kim, J., Park, S., Min, D., & Kim, W. (2021) · International Journal of Molecular Sciences · doi:10.3390/ijms22189983 · Cited by 147
Colli, M. L., Ramos-Rodríguez, M., Nakayasu, E. S., Alvelos, M. I., Lopes, M., Hill, J. L. E., Turatsinze, J., de Brachène, A. C., Russell, M. A., Raurell‐Vila, H., et al. (2020) · Nature Communications · doi:10.1038/s41467-020-16327-0 · Cited by 143
Jäger, B., Schupp, J. C., Plappert, L., Terwolbeck, O., Artysh, N., Kayser, G., Engelhard, P., Adams, T. S., Zweigerdt, R., Kempf, H., et al. (2022) · Nature Communications · doi:10.1038/s41467-022-33193-0 · Cited by 144
A proteome-wide atlas of drug mechanism of action
Mitchell, D. C., Kuljanin, M., Li, J., Vranken, J. G. V., Bulloch, N. J., Schweppe, D. K., Huttlin, E. L., & Gygi, S. P. (2023) · Nature Biotechnology · doi:10.1038/s41587-022-01539-0 · Cited by 146
Artificial intelligence in early drug discovery enabling precision medicine
Boniolo, F., Dorigatti, E., Ohnmacht, A. J., Saur, D., Schubert, B., & Menden, M. P. (2021) · Expert Opinion on Drug Discovery · doi:10.1080/17460441.2021.1918096 · Cited by 147
Exploration of databases and methods supporting drug repurposing: a comprehensive survey
Tanoli, Z., Seemab, U., Scherer, A., Wennerberg, K., Tang, J., & Vähä-Koskela, M. (2021) · Briefings in Bioinformatics · doi:10.1093/bib/bbaa003 · Cited by 131
Morphology and gene expression profiling provide complementary information for mapping cell state
Way, G. P., Natoli, T. E., Adeboye, A., Litichevskiy, L., Yang, A. X., Lü, X., Caicedo, J. C., Cimini, B. A., Karhohs, K. W., Logan, D. J., et al. (2022) · Cell Systems · doi:10.1016/j.cels.2022.10.001 · Cited by 146
Self-citationTian, S., Zhang, J., Yuan, S., Wang, Q., Lv, C., Wang, J., Fang, J., Fu, L., Yang, J., Zu, X., et al. (2023) · Briefings in Bioinformatics · doi:10.1093/bib/bbad027 · Cited by 137
Artificial Intelligence in Pharmaceutical Sciences
Lu, M., Yin, J., Zhu, Q., Lin, G., Mou, M., Liu, F., Pan, Z., You, N., Lian, X., Li, F., et al. (2023) · Engineering · doi:10.1016/j.eng.2023.01.014 · Cited by 145
Machine learning for perturbational single-cell omics
Ji, Y., Lotfollahi, M., Wolf, F. A., & Theis, F. J. (2021) · Cell Systems · doi:10.1016/j.cels.2021.05.016 · Cited by 137
Learning representations for image-based profiling of perturbations
Moshkov, N., Bornholdt, M., Benoit, S., Smith, M., McQuin, C., Goodman, A., Senft, R. A., Han, Y., Babadi, M., Horváth, P., et al. (2024) · Nature Communications · doi:10.1038/s41467-024-45999-1 · Cited by 147
Kim, H., Kim, E., Lee, I., Bae, B., Park, M., & Nam, H. (2020) · Biotechnology and Bioprocess Engineering · doi:10.1007/s12257-020-0049-y · Cited by 146
Beyondcell: targeting cancer therapeutic heterogeneity in single-cell RNA-seq data
Torre, C. F., Jiménez‐Santos, M. J., García‐Martín, S., Carretero-Puche, C., García-Jimeno, L., Ivanchuk, V., Domenico, T. D., Goméz-López, G., & Al‐Shahrour, F. (2021) · Genome Medicine · doi:10.1186/s13073-021-01001-x · Cited by 131
Alexander-Dann, B., Pruteanu, L.-L., Oerton, E., Sharma, N., Berindan‐Neagoe, I., Módos, D., & Bender, A. (2018) · Molecular Omics · doi:10.1039/c8mo00042e · Cited by 142
Afantitis, A., Melagraki, G., Isigonis, P., Tsoumanis, A., Varsou, D., Valsami‐Jones, E., Papadiamantis, A. G., Ellis, L. A., Sarimveis, H., Doganis, P., et al. (2020) · Computational and Structural Biotechnology Journal · doi:10.1016/j.csbj.2020.02.023 · Cited by 133
Lee, J. J., Bernard, V., Semaan, A., Monberg, M. E., Huang, J., Stephens, B. M., Lin, D., Rajapakshe, K. I., Weston, B. R., Bhutani, M. S., et al. (2021) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-20-3925 · Cited by 128
Extending the small-molecule similarity principle to all levels of biology with the Chemical Checker
Duran-Frigola, M., Pauls, E., Guitart-Pla, O., Bertoni, M., Alcalde, V., Amat, D., Juan-Blanco, T., & Aloy, P. (2020) · Nature Biotechnology · doi:10.1038/s41587-020-0502-7 · Cited by 126
Advances and Challenges in Computational Target Prediction
Sydow, D., Burggraaff, L., Szengel, A., van Vlijmen, H., IJzerman, A. P., van Westen, G. J. P., & Volkamer, A. (2019) · Journal of Chemical Information and Modeling · doi:10.1021/acs.jcim.8b00832 · Cited by 130
In silico cancer research towards 3R
Jean-Quartier, C., Jeanquartier, F., Jurišica, I., & Holzinger, A. (2018) · BMC Cancer · doi:10.1186/s12885-018-4302-0 · Cited by 132
Lian, H., Han, Y., Zhang, Y., Zhao, Y., Yan, S., Li, Q., Wang, B., Wang, J., Meng, W., Yang, J., et al. (2019) · Molecular Oncology · doi:10.1002/1878-0261.12557 · Cited by 124
Liao, J., Yang, B., Zhang, Y., Wang, X., Ye, Y., Peng, J.-W., Yang, Z.-Z., He, J., Zhang, Y., Hu, K., et al. (2019) · Nucleic Acids Research · doi:10.1093/nar/gkz823 · Cited by 122
Ochsner, S. A., Abraham, D., Martin, K. A., Ding, W., McOwiti, A., Kankanamge, W. H., Wang, Z., Andreano, K. J., Hamilton, R. A., Chen, Y., et al. (2019) · Scientific Data · doi:10.1038/s41597-019-0193-4 · Cited by 119
Efficient Generation of Transcriptomic Profiles by Random Composite Measurements
Cleary, B., Cong, L., Cheung, A., Lander, E. S., & Regev, A. (2017) · Cell · doi:10.1016/j.cell.2017.10.023 · Cited by 114
Lessons from the COVID-19 pandemic for advancing computational drug repurposing strategies
Galindez, G., Matschinske, J., Rose, T. D., Sadegh, S., Salgado-Albarrán, M., Späth, J., Baumbach, J., & Pauling, J. K. (2021) · Nature Computational Science · doi:10.1038/s43588-020-00007-6 · Cited by 123
Taroni, J., Grayson, P. C., Hu, Q., Eddy, S. F., Kretzler, M., Merkel, P. A., & Greene, C. S. (2019) · Cell Systems · doi:10.1016/j.cels.2019.04.003 · Cited by 119
Appyters: Turning Jupyter Notebooks into data-driven web apps
Clarke, D. J. B., Jeon, M., Stein, D. J., Moiseyev, N., Kropiwnicki, E., Dai, C. S., Xie, Z., Wojciechowicz, M. L., Litz, S., Hom, J., et al. (2021) · Patterns · doi:10.1016/j.patter.2021.100213 · Cited by 129
SigCom LINCS: data and metadata search engine for a million gene expression signatures
Evangelista, J. E., Clarke, D. J. B., Xie, Z., Lachmann, A., Jeon, M., Chen, K., Jagodnik, K. M., Jenkins, S. L., Kuleshov, M. V., Wojciechowicz, M. L., et al. (2022) · Nucleic Acids Research · doi:10.1093/nar/gkac328 · Cited by 118
do Valle, Í. F., Roweth, H. G., Malloy, M. W., Moco, S., Barron, D., Battinelli, E. M., Loscalzo, J., & Barabási, A.-Ĺ. (2021) · Nature Food · doi:10.1038/s43016-021-00243-7 · Cited by 120
Drug Repositioning in Glioblastoma: A Pathway Perspective
Tan, S. K., Jermakowicz, A. M., Mookhtiar, A. K., Nemeroff, C. B., Schürer, S. C., & Ayad, N. G. (2018) · Frontiers in Pharmacology · doi:10.3389/fphar.2018.00218 · Cited by 116
The genesis and evolution of bead-based multiplexing
Graham, H., Chandler, D. J., & Dunbar, S. A. (2019) · Methods · doi:10.1016/j.ymeth.2019.01.007 · Cited by 116
Ahangari, F., Becker, C., Foster, D. G., Chioccioli, M., Nelson, M., Beke, K. M., Wang, X., Justet, A., Adams, T. S., Readhead, B. P., et al. (2022) · American Journal of Respiratory and Critical Care Medicine · doi:10.1164/rccm.202010-3832oc · Cited by 119
Shin, D., Lee, W., Lee, J. H., & Bang, D. (2019) · Science Advances · doi:10.1126/sciadv.aav2249 · Cited by 101
The efficacy of chemotherapy is limited by intratumoral senescent cells expressing PD-L2
Chaib, S., López-Domínguez, J. A., Lalinde-Gutiérrez, M., Prats, N., Marin, I., Boix, O., García-Garijo, A., Meyer, K., Muñoz, M. I., Aguilera, M., et al. (2024) · Nature Cancer · doi:10.1038/s43018-023-00712-x · Cited by 114
Predicting compound activity from phenotypic profiles and chemical structures
Moshkov, N., Becker, T., Yang, K., Horváth, P., Dančík, V., Wagner, B. K., Clemons, P. A., Singh, S., Carpenter, A. E., & Caicedo, J. C. (2023) · Nature Communications · doi:10.1038/s41467-023-37570-1 · Cited by 123
Self-citationPan-cancer proteogenomics connects oncogenic drivers to functional states
Li, Y., Porta‐Pardo, E., Tokheim, C. J., Bailey, M. H., Yaron, T. M., Stathias, V., Geffen, Y., Imbach, K. J., Cao, S., Anand, S. K., et al. (2023) · Cell · doi:10.1016/j.cell.2023.07.014 · Cited by 124
Navigating the complexities of drug development for inflammatory bowel disease
Honap, S., Jairath, V., Danese, S., & Peyrin‐Biroulet, L. (2024) · Nature Reviews Drug Discovery · doi:10.1038/s41573-024-00953-0 · Cited by 123
Molecular Pathophysiology of Chronic Wounds: Current State and Future DirectionsPreprint
Pastar, I., Balukoff, N. C., Marjanović, J., Chen, V. Y., Stone, R. C., & Tomic‐Canic, M. (2022) · Cold Spring Harbor Perspectives in Biology · doi:10.1101/cshperspect.a041243 · Cited by 126
DrugShot: querying biomedical search terms to retrieve prioritized lists of small molecules
Kropiwnicki, E., Lachmann, A., Clarke, D. J. B., Xie, Z., Jagodnik, K. M., & Ma’ayan, A. (2022) · BMC Bioinformatics · doi:10.1186/s12859-022-04590-5 · Cited by 112
Corsi, S. R., DeCicco, L., Villeneuve, D. L., Blackwell, B. R., Fay, K. A., Ankley, G. T., & Baldwin, A. K. (2019) · The Science of The Total Environment · doi:10.1016/j.scitotenv.2019.05.457 · Cited by 110
A STAT3-based gene signature stratifies glioma patients for targeted therapy
Tan, M. S. Y., Sandanaraj, E., Chong, Y. K., Lim, S. W., Koh, L., Ng, W. H., Tan, N. S., Tan, P. B. O., Ang, B. T., & Tang, C. (2019) · Nature Communications · doi:10.1038/s41467-019-11614-x · Cited by 109
Lin, E., Lin, C., & Lane, H. (2020) · Molecules · doi:10.3390/molecules25143250 · Cited by 113
Gamberi, T., Chiappetta, G., Fiaschi, T., Modesti, A., Sorbi, F., & Magherini, F. (2021) · Medicinal Research Reviews · doi:10.1002/med.21872 · Cited by 110
Single-cell multiomics analysis reveals regulatory programs in clear cell renal cell carcinoma
Long, Z., Sun, C., Tang, M., Wang, Y., Ma, J., Yu, J., Wei, J., Ma, J., Wang, B., Xie, Q., et al. (2022) · Cell Discovery · doi:10.1038/s41421-022-00415-0 · Cited by 109
Network-based screen in iPSC-derived cells reveals therapeutic candidate for heart valve disease
Theodoris, C. V., Zhou, P., Liu, L., Zhang, Y., Nishino, T., Huang, Y., Kostina, A., Ranade, S. S., Gifford, C. A., Uspenskiy, V., et al. (2021) · Science · doi:10.1126/science.abd0724 · Cited by 105
Application of omics- and multi-omics-based techniques for natural product target discovery
Zhang, H., Lv, C., Zhang, L., Guo, X., Shen, Y., Nagle, D. G., Zhou, Y., Liu, S., Zhang, W., & Luan, X. (2021) · Biomedicine & Pharmacotherapy · doi:10.1016/j.biopha.2021.111833 · Cited by 115
Haghighi, M., Caicedo, J. C., Cimini, B. A., Carpenter, A. E., & Singh, S. (2022) · Nature Methods · doi:10.1038/s41592-022-01667-0 · Cited by 109
Network medicine framework for identifying drug-repurposing opportunities for COVID-19
Morselli Gysi, D., do Valle, Í., Zitnik, M., Ameli, A., Gan, X., Varol, O., Ghiassian, S. D., Patten, J. J., Davey, R. A., Loscalzo, J., et al. (2021) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.2025581118 · Cited by 107
Wang, L., Liu, Z., Liang, R., Wang, W., Zhu, R., Li, J., Xing, Z., Weng, S., Han, X., & Sun, Y. (2022) · eLife · doi:10.7554/elife.80150 · Cited by 106
Self-citationHarrill, J. A., Viant, M. R., Yauk, C. L., Sachana, M., Gant, T. W., Auerbach, S. S., Beger, R. D., Bouhifd, M., O'Brien, J., Burgoon, L., et al. (2021) · Regulatory Toxicology and Pharmacology · doi:10.1016/j.yrtph.2021.105020 · Cited by 105
Improving natural product research translation: From source to clinical trial
Sorkin, B. C., Kuszak, A. J., Bloss, G., Fukagawa, N. K., Hoffman, F. A., Jafari, M., Barrett, B. P., Brown, P. N., Bushman, F. D., Casper, S. J., et al. (2019) · The FASEB Journal · doi:10.1096/fj.201902143r · Cited by 110
SAveRUNNER: A network-based algorithm for drug repurposing and its application to COVID-19
Fiscon, G., Conte, F., Farina, L., & Paci, P. (2021) · PLoS Computational Biology · doi:10.1371/journal.pcbi.1008686 · Cited by 108
Drug-drug interactions prediction based on deep learning and knowledge graph: A review
Luo, H., Yin, W., Wang, J., Zhang, G., Liang, W., Luo, J., & Yan, C. (2024) · iScience · doi:10.1016/j.isci.2024.109148 · Cited by 119
Development of a Roadmap for Action on New Approach Methodologies in Risk Assessment
Escher, S. E., Partosch, F., Konzok, S., Jennings, P., Luijten, M., Kienhuis, A. S., de Leeuw, V. C., Reuss, R., Lindemann, K.-M., & Bennekou, S. H. (2022) · EFSA Supporting Publications · doi:10.2903/sp.efsa.2022.en-7341 · Cited by 108
A molecular quantitative trait locus map for osteoarthritis
Steinberg, J., Southam, L., Butterfield, N. C., Roumeliotis, T. I., Fontalis, A., Clark, M. J. R., Jayasuriya, R. L., Swift, D., Shah, K. M., Curry, K. F., et al. (2021) · Nature Communications · doi:10.1038/s41467-021-21593-7 · Cited by 103
Mining data and metadata from the gene expression omnibus
Wang, Z., Lachmann, A., & Ma’ayan, A. (2018) · Biophysical Reviews · doi:10.1007/s12551-018-0490-8 · Cited by 105
TOXRIC: a comprehensive database of toxicological data and benchmarks
Wu, L., Yan, B., Han, J., Li, R., Xiao, J., He, S., & Bo, X. (2022) · Nucleic Acids Research · doi:10.1093/nar/gkac1074 · Cited by 106
scAlign: a tool for alignment, integration, and rare cell identification from scRNA-seq data
Johansen, N., & Quon, G. (2019) · Genome biology · doi:10.1186/s13059-019-1766-4 · Cited by 104
Drug mechanism‐of‐action discovery through the integration of pharmacological and CRISPR screens
Gonçalves, E., Segura‐Cabrera, A., Pacini, C., Picco, G., Behan, F. M., Jaaks, P., Coker, E. A., van der Meer, D., Barthorpe, A. S., Lightfoot, H. W., et al. (2020) · Molecular Systems Biology · doi:10.15252/msb.20199405 · Cited by 106
GRAND: a database of gene regulatory network models across human conditions
Guebila, M. B., Lopes‐Ramos, C. M., Weighill, D. A., Sonawane, A. R., Burkholz, R., Shamsaei, B., Platig, J., Glass, K., Kuijjer, M. L., & Quackenbush, J. F. (2021) · Nucleic Acids Research · doi:10.1093/nar/gkab778 · Cited by 92
Prime-seq, efficient and powerful bulk RNA sequencing
Janjic, A., Wange, L. E., Bagnoli, J., Geuder, J., Nguyen, P., Richter, D., Vieth, B., Vick, B., Jeremias, I., Ziegenhain, C., et al. (2022) · Genome biology · doi:10.1186/s13059-022-02660-8 · Cited by 99
Interpreting pathways to discover cancer driver genes with Moonlight
Colaprico, A., Olsen, C., Bailey, M. H., Odom, G., Terkelsen, T., Silva, T. C., Olsen, A. V., Cantini, L., Zinovyev, A. Y., Barillot, E., et al. (2020) · Nature Communications · doi:10.1038/s41467-019-13803-0 · Cited by 101
Drug target prediction through deep learning functional representation of gene signatures
Chen, H., King, F. J., Zhou, B., Wang, Y., Canedy, C. J., Hayashi, J., Zhong, Y., Chang, M. W., Pache, L., Wong, J. L., et al. (2024) · Nature Communications · doi:10.1038/s41467-024-46089-y · Cited by 107
Rexach, J. E., Polioudakis, D., Yin, A., Swarup, V., Chang, T. S., Nguyen, T., Sarkar, A., Chen, L., Huang, J., Lin, L.-C., et al. (2020) · Cell Reports · doi:10.1016/j.celrep.2020.108398 · Cited by 94
Evaluation of large language models for discovery of gene set function
Hu, M., Alkhairy, S., Lee, I., Pillich, R. T., Fong, D., Smith, K., Bachelder, R., Ideker, T., & Pratt, D. (2025) · Nature Methods · doi:10.1038/s41592-024-02525-x · Cited by 104
Drug and disease signature integration identifies synergistic combinations in glioblastoma
Stathias, V., Jermakowicz, A. M., Maloof, M. E., Forlin, M., Walters, W. M., Suter, R. K., Durante, M. A., Williams, S. L., Harbour, J. W., Volmar, C., et al. (2018) · Nature Communications · doi:10.1038/s41467-018-07659-z · Cited by 101
Self-citationRUNX1-targeted therapy for AML expressing somatic or germline mutation in RUNX1
Mill, C. P., Fiskus, W. C., Dinardo, C. D., Qian, Y., Raina, K., Rajapakshe, K., Perera, D. N., Coarfa, C., Kadia, T. M., Khoury, J. D., et al. (2019) · Blood · doi:10.1182/blood.2018893982 · Cited by 98
Morris, J. H., Soman, K., Akbas, R. E., Zhou, X., Smith, B., Meng, E. C., Huang, C. C., Cerono, G., Schenk, G., Rizk-Jackson, A., et al. (2023) · Bioinformatics · doi:10.1093/bioinformatics/btad080 · Cited by 99
Computational drug repurposing: approaches, evaluation of in silico resources and case studies
Tanoli, Z., Fernández‐Torras, A., Özcan, U. O., Kushnir, A., Nader, K. M., Gadiya, Y., Fiorenza, L., Ianevski, A., Vähä-Koskela, M. J. V., Miihkinen, M., et al. (2025) · Nature Reviews Drug Discovery · doi:10.1038/s41573-025-01164-x · Cited by 104
Ding, J., Blencowe, M., Nghiem, T. X., Ha, S. M., Chen, Y.-W., Li, G., & Yang, X. (2021) · Nucleic Acids Research · doi:10.1093/nar/gkab405 · Cited by 99
Zhang, H., Zhang, Y., Li, Y., Wang, Y., Yan, S., Xu, S., Deng, Z., Yang, X., Xie, H., & Li, J. (2021) · Frontiers in Immunology · doi:10.3389/fimmu.2021.756550 · Cited by 101
Tian, Y., Xiao, H., Yang, Y., Zhang, P., Yuan, J., Zhang, W., Chen, L., Fan, Y., Zhang, J., Cheng, H., et al. (2023) · Molecular Cancer · doi:10.1186/s12943-022-01706-6 · Cited by 97
Wu, X., Zhou, Q., Li, M., & Hu, X. (2022) · Journal of Hazardous Materials · doi:10.1016/j.jhazmat.2022.129487 · Cited by 101
Self-citationPan-cancer proteogenomics characterization of tumor immunity
Petralia, F., Ma, W., Yaron, T. M., Caruso, F. P., Tignor, N. L., Wang, J. M., Charytonowicz, D., Johnson, J. L., Huntsman, E. M., Marino, G. B., et al. (2024) · Cell · doi:10.1016/j.cell.2024.01.027 · Cited by 104
Bioactivity descriptors for uncharacterized chemical compounds
Bertoni, M., Duran-Frigola, M., Badia-i-Mompel, P., Pauls, E., Orozco-Ruiz, M., Guitart-Pla, O., Alcalde, V., Diaz, V. M., Berenguer-Llergo, A., Brun-Heath, I., et al. (2021) · Nature Communications · doi:10.1038/s41467-021-24150-4 · Cited by 92
Drug repurposing to improve treatment of rheumatic autoimmune inflammatory diseases
Kingsmore, K. M., Grammer, A. C., & Lipsky, P. E. (2019) · Nature Reviews Rheumatology · doi:10.1038/s41584-019-0337-0 · Cited by 97
Stable gene expression for normalisation and single-sample scoring
Bhuva, D. D., Cursons, J., & Davis, M. J. (2020) · Nucleic Acids Research · doi:10.1093/nar/gkaa802 · Cited by 91
Applications of Artificial Intelligence in Drug Repurposing
Wan, Z., Sun, X., Li, Y., Chu, T., Hao, X., Cao, Y., & Zhang, P. (2025) · Advanced Science · doi:10.1002/advs.202411325 · Cited by 110
Turning liabilities into opportunities: Off-target based drug repurposing in cancer
Palve, V. C., Liao, Y., Rix, L. L. R., & Rix, U. (2020) · Seminars in Cancer Biology · doi:10.1016/j.semcancer.2020.02.003 · Cited by 96
Patient-derived cell line, xenograft and organoid models in lung cancer therapy
Huo, K.-G., D’Arcangelo, E., & Tsao, M. (2020) · Translational Lung Cancer Research · doi:10.21037/tlcr-20-154 · Cited by 98
Chemical reprogramming for cell fate manipulation: Methods, applications, and perspectives
Wang, J., Sun, S., & Deng, H. (2023) · Cell Stem Cell · doi:10.1016/j.stem.2023.08.001 · Cited by 91
Meyer, J. G., Liu, S., Miller, I. J., Coon, J. J., & Gitter, A. (2019) · Journal of Chemical Information and Modeling · doi:10.1021/acs.jcim.9b00236 · Cited by 92
Evaluating batch correction methods for image-based cell profiling
Arevalo, J., Su, E., van Dijk, R., Carpenter, A. E., & Singh, S. (2023) · doi:10.1101/2023.09.15.558001 · Cited by 89
Metadata
- Authors
- Subramanian, A., Narayan, R., Corsello, S. M., Peck, D. D., Natoli, T. E., Lu, X., Gould, J., Davis, J. F., Tubelli, A. A., Asiedu, J. K., Lahr, D. L., Hirschman, J. E., Liu, Z., Donahue, M., Julian, B., Khan, M., Wadden, D., Smith, I. C., Lam, D., Liberzon, A., Toder, C., Bagul, M., Orzechowski, M., Enache, O. M., Piccioni, F., Johnson, S. A., Lyons, N. J., Berger, A. H., Shamji, A. F., Brooks, A. N., Vrcic, A., Flynn, C., Rosains, J., Takeda, D. Y., Hu, R., Davison, D., Lamb, J., Ardlie, K., Hogstrom, L., Greenside, P., Gray, N. S., Clemons, P. A., Silver, S., Wu, X., Zhao, W.-N., Read-Button, W., Wu, X., Haggarty, S. J., Ronco, L. V., Boehm, J. S., Schreiber, S. L., Doench, J. G., Bittker, J. A., Root, D. E., Wong, B., & Golub, T. R.
- Affiliations
- Broad Institute (US)
- Corresponding author
- Golub, Todd R.
- ORCID
- Subramanian, Aravind
- Corsello, Steven M.
- Gould, Joshua
- Tubelli, Andrew A.
- Lahr, David L.
- Hirschman, Jodi E.
- Liu, Zihan
- Khan, Mariya
- Smith, Ian C.
- Orzechowski, Marek
- Enache, Oana M.
- Piccioni, Federica
- Johnson, Sarah A.
- Berger, Alice H.
- Brooks, Angela N.
- Vrcic, Anita
- Takeda, David Y.
- Ardlie, Kristin
- Gray, Nathanael S.
- Clemons, Paul A.
- Silver, Serena
- Wu, Xiaoyun
- Zhao, Wen-Ning
- Haggarty, Stephen J.
- Ronco, Lucienne V.
- Boehm, Jesse S.
- Schreiber, Stuart L.
- Doench, John G.
- Bittker, Joshua A.
- Root, David E.
- Golub, Todd R.
- Venue
- Cell
- Publisher
- Elsevier BV
- Published
- 2017-11
- Volume
- 171
- Issue
- 6
- Pages
- 1437-1452.e17
- ISSN
- 0092-8674 (ISSN-L)
- PMC
- PMC5990023
- OpenAlex
- W2612467560
- Cited by
- 3,515
- References
- 73
- Citations by year
- 2026: 436 · 2025: 479 · 2024: 493 · 2023: 458 · 2022: 507 · 2021: 421 · 2020: 320 · 2019: 261 · 2018: 122 · 2017: 12
- FWCI
- 80.27
- Type
- journal article
- Language
- en
- Open access
- bronze
- doi.org
- Licence
- Locations
- Cell (publishedVersion)
- bioRxiv (Cold Spring Harbor Laboratory) (acceptedVersion)
- PubMed (publishedVersion)
- Europe PMC (PubMed Central) (acceptedVersion)
- PubMed Central (acceptedVersion)
- eScholarship (California Digital Library) (submittedVersion)
- Funders
- NIH (U54HG006093, U54HL127366, U01HG008699, CA009172, TR001100)
- Conquer Cancer Foundation of ASCO Young
- Topics
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Gene expression and cancer classification
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Bioinformatics and Genomic Networks
- Life Sciences › Pharmacology, Toxicology and Pharmaceutics › Drug Discovery › Computational Drug Discovery Methods
- Keywords
- Connectivity Map, L1000, gene expression signatures, functional annotation of genetic variants, reproducibility, clinical trial design
- MeSH terms
- Pharmaceutical Preparations, Humans, Neoplasms, Organ Specificity, Sequence Analysis, RNA, Drug Resistance, Neoplasm, Gene Expression Profiling, Cell Line, Tumor, Small Molecule Libraries
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
